A survey on drug safety for physician resident

被引：0
|
作者：
Abou Taam, M. [1 ]
Ga, C. [1 ]
Trenque, T. [1 ]
机构：
[1] Ctr Reg Pharmacovigilance & Pharmacoepidemiol, Reims, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-017
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] The Association Between Resident Physician Work-Hour Regulations and Physician Safety and Health
    Weaver, Matthew D.
    Landrigan, Christopher P.
    Sullivan, Jason P.
    O'Brien, Conor S.
    Qadri, Salim
    Viyaran, Natalie
    Wang, Wei
    Vetter, Celine
    Czeisler, Charles A.
    Barger, Laura K.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (07): : E343 - E354
  • [2] A SURVEY OF PHYSICIAN KNOWLEDGE OF DRUG COSTS
    HOFFMAN, J
    BAREFIELD, FA
    RAMAMURTHY, S
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (06) : 432 - 435
  • [3] The physician's role in drug safety
    Avorn, J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S93 - S93
  • [4] Resident physician burnout: insights from a Canadian multispecialty survey
    Ferguson, Craig
    Low, Gavin
    Shiau, Gillian
    POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1136) : 331 - 338
  • [5] Resident Physician
    Samani, Elham Neisani
    Sanjaghsaz, Hamid
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 204 - 204
  • [6] Improving Resident Physician Participation in Reporting Patient Safety and Quality Concerns
    Craig, Steven R.
    Smith, Hayden L.
    Shaeffer, Patrick J.
    OCHSNER JOURNAL, 2024, 24 (02): : 118 - 123
  • [7] EFFECTS OF POLICY PROHIBITING EXTENDED SHIFTS ON PATIENT AND RESIDENT PHYSICIAN SAFETY
    Weaver, M. D.
    Sullivan, J. P.
    O'Brien, C. S.
    Qadri, S.
    Viyaran, N.
    Wang, W.
    Vetter, C.
    Landrigan, C. P.
    Czeisler, C. A.
    Barger, L. K.
    SLEEP, 2018, 41 : A389 - A389
  • [8] Drug Utilization Physician Survey of Intron A® in Europe
    Laudati, Jamie T.
    Ahmed, Shirin
    Jo, Eu Jung
    Arana, Alejandro
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S157 - S158
  • [9] Bill Inman: a drug safety physician and pharmacoepidemiologist
    Shakir, SAW
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (04) : 279 - 280
  • [10] Bill Inman: Drug Safety Physician and Pharmacoepidemiologist
    Saad A.W. Shakir
    Drug Safety, 2006, 29 : 187 - 188
12345